Skip to main content
. 2021 Aug 12;70:103534. doi: 10.1016/j.ebiom.2021.103534

Table 1.

Serostatus at baseline (Ischgl 1) and follow-up (Ischgl 2)

Serostatus at follow-up (Ischgl 2), n (%), NT+/total NT assays
Positive - p Discordant - d IgA only - a Negative - n Total
Serostatus at baseline (Ischgl 1), n (%), NTpos/total NT assays Positive - p 276 (34.5)
244 NTpos/276
82 (10.2)
63 NTpos/82
2 (0.2)
2 NTpos/2
4 (0.5)
3 NTpos/4
364
Discordant - d 4 (0.5)
2 NTpos/4
30 (3.7)
13 NTpos/30
1 (0.1)
0 NTpos/1
8 (1.0)
2 NTpos/7
43
IgA only - a 0 (0.0) 1 (0.1)
0 NTpos/1
3 (0.4)
0 NTpos/3
7 (0.9)
0 NTpos/7
11
Negative - n 4 (0.5)
3 NTpos/4
5 (0.6)
2 NTpos/5
2 (0.2)
0 NTpos/2
372 (46.4)
6 NTpos/246
383
Total 284 (35.5) 118 (14.7) 8 (1.0) 391 (48.8) 801

NTpos (Neutralizing antibody titer positive) = titer ≥1:16